These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21041973)

  • 61. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment].
    Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A
    Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis.
    Nitta K; Kawashima A; Yumura W; Naruse M; Oba T; Kabaya T; Nihei H
    Am J Nephrol; 1998; 18(5):411-5. PubMed ID: 9730565
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Lui SF; Sanderson JE
    Kidney Int; 2006 Aug; 70(3):444-52. PubMed ID: 16871255
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multimarker approach to risk stratification for long-term mortality in patients on chronic hemodialysis.
    Ishii J; Takahashi H; Kitagawa F; Kuno A; Okuyama R; Kawai H; Muramatsu T; Naruse H; Motoyama S; Matsui S; Hasegawa M; Aoyama T; Kamoi D; Kasuga H; Izawa H; Ozaki Y; Yuzawa Y
    Circ J; 2015; 79(3):656-63. PubMed ID: 25746551
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimal fluid control can normalize cardiovascular risk markers and limit left ventricular hypertrophy in thrice weekly dialysis patients.
    Velasco N; Chamney P; Wabel P; Moissl U; Imtiaz T; Spalding E; McGregor M; Innes A; MacKay I; Patel R; Jardine A
    Hemodial Int; 2012 Oct; 16(4):465-72. PubMed ID: 22515643
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.
    Sinha MD; Turner C; Booth CJ; Waller S; Rasmussen P; Goldsmith DJ; Simpson JM
    Pediatr Nephrol; 2015 Oct; 30(10):1843-52. PubMed ID: 25975437
    [TBL] [Abstract][Full Text] [Related]  

  • 67. FGF-23 and cognitive performance in hemodialysis patients.
    Drew DA; Tighiouart H; Scott TM; Lou KV; Fan L; Shaffi K; Weiner DE; Sarnak MJ
    Hemodial Int; 2014 Jan; 18(1):78-86. PubMed ID: 24164913
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
    Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predictive factors associated with left ventricular hypertrophy at baseline and in the follow-up period in non-diabetic hemodialysis patients.
    Io H; Matsumoto M; Okumura K; Sato M; Masuda A; Furukawa M; Nohara N; Tanimoto M; Kodama F; Hagiwara S; Gohda T; Shimizu Y; Tomino Y
    Semin Dial; 2011; 24(3):349-54. PubMed ID: 20723158
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [B-type natriuretic peptide as a marker of cardiac dysfunction in children with chronic kidney disease].
    Drożdż T; Kwinta P; Kordon Z; Sztefko K; Rudziński A; Zachwieja K; Miklaszewska M; Czarnecka D; Drożdż D
    Pol Merkur Lekarski; 2018 Apr; 44(262):171-176. PubMed ID: 29775443
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effects of high flow hemodialysis on the biomarker of myocardium injury and the cardiac function related records in uremia patients].
    Tang L; Deng X; Dai Q; Xiao H; Shu Y; Jiang M; Wei L; Wang L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):547-550. PubMed ID: 28625246
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
    Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
    Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Tamura M; Anai H; Kabashima N; Suda T; Iwamoto M; Ota T; Watanabe Y; Kanegae K; Nakashima Y
    Nephron; 2002 Dec; 92(4):832-9. PubMed ID: 12399629
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Associations of sensitive cardiac troponin-I with left ventricular morphology, function and prognosis in end-stage renal disease patients with preserved ejection fraction.
    Otsuka K; Nakanishi K; Shimada K; Nakamura H; Inanami H; Nishioka H; Fujimoto K; Kasayuki N; Yoshiyama M
    Heart Vessels; 2018 Nov; 33(11):1334-1342. PubMed ID: 29789900
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients
.
    Ganidagli B; Nacar H; Yildiz YS; Dagli H; Erken E; Altunoren O; Gungor O
    Clin Nephrol; 2019 Jan; 91(1):9-16. PubMed ID: 30369401
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Possible involvement of TNF-alpha in left ventricular remodeling in hemodialysis patients.
    Nishimura M; Hashimoto T; Kobayashi H; Fukukda T; Okino K; Yamamoto N; Nakamura N; Yoshikawa T; Takahashi H; Ono T
    J Nephrol; 2003; 16(5):641-9. PubMed ID: 14733409
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis.
    Kim BS; Jeon DS; Shin MJ; Kim YO; Song HC; Lee SH; Kim SY; Choi EJ; Chang YS; Bang BK
    Am J Nephrol; 2005; 25(3):189-95. PubMed ID: 15863980
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predictors of congestive heart failure in patients on maintenance hemodialysis.
    Ito S; Murai S; Sugiura M; Yoshida T; Fukutomi T
    Circ J; 2007 Sep; 71(9):1424-9. PubMed ID: 17721022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.